INSPIRE VETERINARY PARTNER Financials
INSPIRE VETERINARY PARTNER (IVP) reported $15.6M in revenue over the twelve months to Sep 30, 2025, down 8.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
The dominant mechanic is revenue stagnation alongside escalating operating costs, forcing financing to absorb widening cash needs.
Positive equity in FY2024 coincided with financing cash flow of$10.6M while operations consumed-$10.0M , suggesting external financing was offsetting operating losses rather than internally generated cash funding the business. Because free cash flow reached-$10.2M against operating cash flow of-$10.0M , capital spending was only a small part of the cash shortfall.
Operating efficiency deteriorated: revenue was essentially flat at
Short-term funding is tight: a 0.2x current ratio in FY2024 signals that near-term obligations materially exceed current resources. Goodwill was
Financial Health Signals
INSPIRE VETERINARY PARTNER does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
INSPIRE VETERINARY PARTNER scores -3.41, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($4.0M) relative to total liabilities ($18.6M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
INSPIRE VETERINARY PARTNER passes 3 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 1 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, both operating efficiency signals pass.
INSPIRE VETERINARY PARTNER reported a net loss of $14.3M while operations used $10.0M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
INSPIRE VETERINARY PARTNER generated $16.6M in revenue in fiscal year 2024. This represents a decrease of 0.5% from the prior year.
INSPIRE VETERINARY PARTNER's EBITDA was -$7.7M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 29.8% from the prior year.
INSPIRE VETERINARY PARTNER reported -$14.3M in net income in fiscal year 2024. This represents an increase of 3.6% from the prior year.
Not reported for fiscal year 2024.
Cash & Balance Sheet
INSPIRE VETERINARY PARTNER recorded an outflow of $10.2M in free cash flow in fiscal year 2024, representing a cash shortfall after capex. This represents a decrease of 143.6% from the prior year.
INSPIRE VETERINARY PARTNER held $524K in cash against $12.0M in long-term debt as of fiscal year 2024.
Not reported for fiscal year 2024.
Margins & Returns
INSPIRE VETERINARY PARTNER's operating margin was -54.4% in fiscal year 2024, reflecting core business profitability. This is down 11.4 percentage points from the prior year.
INSPIRE VETERINARY PARTNER's net profit margin was -86.0% in fiscal year 2024, showing the share of revenue converted to profit. This is up 2.7 percentage points from the prior year.
INSPIRE VETERINARY PARTNER's ROE was -913.2% in fiscal year 2024, measuring profit generated per dollar of shareholder equity.
Not reported for fiscal year 2024.
Capital Allocation
INSPIRE VETERINARY PARTNER spent $650K on share buybacks in fiscal year 2024, returning capital to shareholders by reducing shares outstanding.
INSPIRE VETERINARY PARTNER invested $238K in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 38.0% from the prior year.
Not reported for fiscal year 2024.
IVP Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.3M+0.8% | $4.3M+17.7% | $3.6M+9.6% | $3.3M-18.0% | $4.0M-7.8% | $4.4M-9.1% | $4.8M+27.7% | $3.8M |
| SG&A Expenses | $2.4M-8.6% | $2.7M+8.3% | $2.4M-26.8% | $3.3M+11.8% | $3.0M+34.7% | $2.2M-22.8% | $2.9M+29.0% | $2.2M |
| Operating Income | -$2.0M+24.8% | -$2.6M-30.3% | -$2.0M-30.7% | -$1.5M+31.3% | -$2.2M+6.6% | -$2.4M+16.4% | -$2.9M-19.0% | -$2.4M |
| Net Income | -$2.5M+16.8% | -$3.0M-25.7% | -$2.4M+39.1% | -$4.0M-13.7% | -$3.5M-3.0% | -$3.4M+1.0% | -$3.4M+17.4% | -$4.1M |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Interest Expense, Income Tax, EPS (Diluted).
IVP Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $24.0M+15.1% | $20.8M+0.7% | $20.7M+2.3% | $20.2M-9.8% | $22.4M+2.1% | $21.9M-6.3% | $23.4M+7.4% | $21.8M |
| Current Assets | $3.8M+186.9% | $1.3M-54.0% | $2.9M+43.4% | $2.0M-54.5% | $4.5M+102.1% | $2.2M-29.9% | $3.1M+132.2% | $1.4M |
| Cash & Equivalents | $576K+46.5% | $393K-78.8% | $1.9M+254.8% | $524K-23.1% | $681K+8795.3% | $8K-88.9% | $69K-61.4% | $179K |
| Inventory | $498K+4.3% | $477K+0.4% | $475K-8.0% | $517K-8.3% | $564K-1.9% | $575K+5.3% | $546K-4.5% | $572K |
| Accounts Receivable | $29K-84.4% | $184K+4096.4% | $4K-89.2% | $41K-64.8% | $116K+190.9% | $40K-88.4% | $341K+1095.1% | $29K |
| Goodwill | $9.1M+1.1% | $9.0M+12.0% | $8.0M0.0% | $8.0M0.0% | $8.0M-1.5% | $8.1M0.0% | $8.1M0.0% | $8.1M |
| Total Liabilities | $19.8M-2.8% | $20.4M+15.3% | $17.7M-5.2% | $18.6M-3.8% | $19.4M-22.7% | $25.0M+8.3% | $23.1M+2.4% | $22.6M |
| Current Liabilities | $9.7M-3.3% | $10.1M+34.5% | $7.5M-8.9% | $8.2M+16.7% | $7.0M-43.4% | $12.4M+46.9% | $8.5M+11.5% | $7.6M |
| Long-Term Debt | $11.8M-2.3% | $12.0M+4.4% | $11.5M-3.8% | $12.0M-3.6% | $12.4M-14.9% | $14.6M | N/A | N/A |
| Total Equity | $4.2M+834.1% | $446K-85.1% | $3.0M+92.3% | $1.6M-48.4% | $3.0M+197.3% | -$3.1M-1254.1% | $270K+134.2% | -$788K |
| Retained Earnings | -$44.3M-6.0% | -$41.8M-7.8% | -$38.8M-6.6% | -$36.4M-14.5% | -$31.7M-12.4% | -$28.2M-13.7% | -$24.8M-17.1% | -$21.2M |
IVP Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.3M-42.8% | -$898K+34.6% | -$1.4M-102.8% | -$678K+89.3% | -$6.3M-4314.0% | $150K+104.7% | -$3.2M-319.9% | -$755K |
| Capital Expenditures | $43K+245.5% | $13K-38.0% | $20K-36.3% | $32K+24.7% | $26K+7.7% | $24K-84.9% | $157K+563.7% | $24K |
| Free Cash Flow | -$1.3M-45.6% | -$911K+34.7% | -$1.4M-96.6% | -$709K+88.8% | -$6.3M-5126.4% | $126K+103.8% | -$3.3M-327.3% | -$778K |
| Investing Cash Flow | -$43K+97.7% | -$1.9M-9086.6% | -$20K+36.3% | -$32K-24.7% | -$26K-7.7% | -$24K+84.9% | -$157K+89.6% | -$1.5M |
| Financing Cash Flow | $1.5M+16.4% | $1.3M-48.7% | $2.5M+358.3% | $552K-92.1% | $7.0M+3838.7% | -$187K-105.8% | $3.2M+371.0% | $683K |
| Dividends Paid | N/A | N/A | N/A | $0 | $0-100.0% | $9K-96.0% | $212K+54.5% | $137K |
Not reported in any period shown, so not listed: Share Buybacks.
IVP Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -45.6%+15.5pp | -61.1%-5.9pp | -55.2%-8.9pp | -46.2%+9.0pp | -55.2%-0.7pp | -54.5%+4.7pp | -59.3%+4.3pp | -63.6% |
| Net Margin | -58.5%+12.3pp | -70.8%-4.5pp | -66.4% | -119.4% | -86.2%-9.1pp | -77.1%-6.3pp | -70.8% | -109.5% |
| Return on Equity | -60.6%+619.4pp | -680.0%-599.6pp | -80.4%+173.5pp | -253.9%-138.8pp | -115.2% | N/A | -1268.0% | N/A |
| Return on Assets | -10.5%+4.0pp | -14.6%-2.9pp | -11.7%+7.9pp | -19.6%-4.1pp | -15.6%-0.1pp | -15.4%-0.8pp | -14.6%+4.4pp | -19.0% |
| Current Ratio | 0.39+0.3x | 0.13-0.3x | 0.39+0.1x | 0.25-0.4x | 0.63+0.5x | 0.18-0.2x | 0.37+0.2x | 0.18 |
| Debt-to-Equity | 2.82-24.1x | 26.96+23.1x | 3.84-3.8x | 7.67+3.6x | 4.10 | N/A | 85.70 | N/A |
| FCF Margin | -30.7%-9.5pp | -21.3%+17.1pp | -38.3%-17.0pp | -21.4% | -156.4% | 2.9%+71.7pp | -68.8%-48.3pp | -20.6% |
Not reported in any period shown, so not listed: Gross Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin, FCF Margin.
Note: The current ratio is below 1.0 (0.25), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Where INSPIRE VETERINARY PARTNER Ranks
Frequently Asked Questions
What is INSPIRE VETERINARY PARTNER's annual revenue?
INSPIRE VETERINARY PARTNER (IVP) reported $16.6M in total revenue for fiscal year 2024. This represents a -0.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is INSPIRE VETERINARY PARTNER's revenue growing?
INSPIRE VETERINARY PARTNER (IVP) revenue declined by 0.5% year-over-year, from $16.7M to $16.6M in fiscal year 2024.
Is INSPIRE VETERINARY PARTNER profitable?
No, INSPIRE VETERINARY PARTNER (IVP) reported a net income of -$14.3M in fiscal year 2024, with a net profit margin of -86.0%.
What is INSPIRE VETERINARY PARTNER's EBITDA?
INSPIRE VETERINARY PARTNER (IVP) had EBITDA of -$7.7M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does INSPIRE VETERINARY PARTNER have?
As of fiscal year 2024, INSPIRE VETERINARY PARTNER (IVP) had $524K in cash and equivalents against $12.0M in long-term debt.
What is INSPIRE VETERINARY PARTNER's operating margin?
INSPIRE VETERINARY PARTNER (IVP) had an operating margin of -54.4% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is INSPIRE VETERINARY PARTNER's net profit margin?
INSPIRE VETERINARY PARTNER (IVP) had a net profit margin of -86.0% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is INSPIRE VETERINARY PARTNER's return on equity (ROE)?
INSPIRE VETERINARY PARTNER (IVP) has a return on equity of -913.2% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is INSPIRE VETERINARY PARTNER's free cash flow?
INSPIRE VETERINARY PARTNER (IVP) recorded an outflow of $10.2M in free cash flow during fiscal year 2024. This represents a -143.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is INSPIRE VETERINARY PARTNER's operating cash flow?
INSPIRE VETERINARY PARTNER (IVP) recorded an outflow of $10.0M in operating cash flow during fiscal year 2024, representing cash used by core business activities.
What are INSPIRE VETERINARY PARTNER's total assets?
INSPIRE VETERINARY PARTNER (IVP) had $20.2M in total assets as of fiscal year 2024, including both current and long-term assets.
What are INSPIRE VETERINARY PARTNER's capital expenditures?
INSPIRE VETERINARY PARTNER (IVP) invested $238K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
What is INSPIRE VETERINARY PARTNER's current ratio?
INSPIRE VETERINARY PARTNER (IVP) had a current ratio of 0.25 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.
What is INSPIRE VETERINARY PARTNER's debt-to-equity ratio?
INSPIRE VETERINARY PARTNER (IVP) had a debt-to-equity ratio of 7.67 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is INSPIRE VETERINARY PARTNER's return on assets (ROA)?
INSPIRE VETERINARY PARTNER (IVP) had a return on assets of -70.6% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is INSPIRE VETERINARY PARTNER's Altman Z-Score?
INSPIRE VETERINARY PARTNER (IVP) has an Altman Z-Score of -3.41, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is INSPIRE VETERINARY PARTNER's Piotroski F-Score?
INSPIRE VETERINARY PARTNER (IVP) has a Piotroski F-Score of 3 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are INSPIRE VETERINARY PARTNER's earnings high quality?
INSPIRE VETERINARY PARTNER (IVP) reported a net loss of $14.3M while operations used $10.0M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.